Strata Critical Medical (SRTA) Operating Expenses (2019 - 2026)

Strata Critical Medical (SRTA) has 8 years of Operating Expenses data on file, last reported at $17.1 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $17.1 million, up 34.17% year-over-year; the trailing twelve-month figure through Mar 2026 was $64.9 million (up 6.38% YoY), and the FY2025 annual result was $63.5 million, up 21.81% from the prior year.
• Operating Expenses grew to $17.1 million in Q1 2026 per SRTA's latest filing, from -$82.8 million in the prior quarter.
• Over five years, Operating Expenses peaked at $83.1 million in Q4 2023 and troughed at -$82.8 million in Q4 2025.
• A 5-year average of $30.9 million and a median of $54.9 million in 2025 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses surged 1003.57% in 2023, then slumped 190.16% in 2024.
• A 5-year view of Operating Expenses shows it stood at -$8.1 million in 2022, then soared by 1125.94% to $83.1 million in 2023, then tumbled by 190.16% to -$74.9 million in 2024, then slipped by 10.52% to -$82.8 million in 2025, then surged by 120.64% to $17.1 million in 2026.
• Business Quant data shows SRTA's Operating Expenses at $17.1 million in Q1 2026, -$82.8 million in Q4 2025, and $54.9 million in Q3 2025.